Abstract:Ferroptosis, distinct from apoptosis, necrosis, and autophagy, is a unique type of cell death driven by iron-dependent phospholipid peroxidation. Since ferroptosis was defined in 2012, it has received widespread attention from researchers worldwide. From a biochemical perspective, the regulation of ferroptosis is strongly associated with cellular metabolism, primarily including iron metabolism, lipid metabolism, and redox metabolism. The distinctive regulatory mechanism of ferroptosis holds great potential for overcoming drug resistance—a major challenge in treating cancer. The considerable role of nanobiotechnology in disease treatment has been widely reported, but further and more systematic discussion on how nanobiotechnology enhances the therapeutic efficacy on ferroptosis-associated diseases still needs to be improved. Moreover, while the exciting therapeutic potential of ferroptosis in cancer has been relatively well summarized, its applications in other diseases, such as neurodegenerative diseases, cardiovascular and cerebrovascular diseases, and kidney disease, remain underreported. Consequently, it is necessary to fill these gaps to further complete the applications of nanobiotechnology in ferroptosis. In this review, we provide an extensive introduction to the background of ferroptosis and elaborate its regulatory network. Subsequently, we discuss the various advantages of combining nanobiotechnology with ferroptosis to enhance therapeutic efficacy and reduce the side effects of ferroptosis-associated diseases. Finally, we analyze and discuss the feasibility of nanobiotechnology and ferroptosis in improving clinical treatment outcomes based on clinical needs, as well as the current limitations and future directions of nanobiotechnology in the applications of ferroptosis, which will not only provide significant guidance for the clinical applications of ferroptosis and nanobiotechnology but also accelerate their clinical translations.

Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.

Ferroptosis-Inducing Nanomedicine for Cancer Therapy

Regulation of Ferroptosis by Nanotechnology for Enhanced Cancer Immunotherapy.

Biomaterial-Mediated Metabolic Regulation of Ferroptosis for Cancer Immunotherapy.

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology

Ferroptosis in Antitumor Therapy: Unraveling Regulatory Mechanisms and Immunogenic Potential

Nanobiotechnology boosts ferroptosis: opportunities and challenges

Inorganic Nanomedicine—Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Ferroptosis in cancer immunity and immunotherapy: Multifaceted interplay and clinical implications

Ferroptosis in Cancer Treatment: Another Way to Rome

Ferroptosis-related Metabolic Mechanism and Nanoparticulate Anticancer Drug Delivery Systems Based on Ferroptosis

Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications

Targeting Ferroptosis for Cancer Therapy: Iron Metabolism and Anticancer Immunity.

Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects

Ferroptosis and its emerging role in tumor

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design